Mechanical thrombectomy in nonagenarians: real-world outcomes from a highly selected cohort treated at a comprehensive stroke center
5 affiliations
- 1Department of Adult Neurology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
- 2Department of Adult Neurology, University Clinical Centre, Gdańsk, Poland
- 32nd Department of Radiology, Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, Gdańsk, Poland
- 4Department of Radiology, University Clinical Centre, Gdańsk, Poland
- 5Translational Brain Diseases Centre, The Fahrenheit Union of Universities, Gdańsk, Poland
Abstract
Background: Evidence supporting mechanical thrombectomy (MT) in very elderly patients remains limited, as nonagenarians are underrepresented in randomized trials and frequently excluded from MT in routine practice. We evaluated the effectiveness and safety of MT in carefully selected patients aged ≥ 90 years treated at a comprehensive stroke center.
Methods: We conducted a retrospective single-center cohort study including consecutive patients with anterior circulation large vessel occlusion treated with MT. Fifty nonagenarians treated between 2017 and 2025 were compared with 100 younger patients treated in 2023. In both groups, only patients with preserved pre-stroke functional independence (modified Rankin Scale [mRS] 0–2) were included. Nonagenarians underwent detailed pre-treatment clinical assessment prior to treatment. Primary outcomes were functional independence (mRS 0–2) and all-cause mortality at 90 days. Secondary outcomes included successful reperfusion (mTICI 2b–3), neurological status at discharge, and hemorrhagic complications. Multivariable regression models were used to adjust for baseline imbalances and clinically relevant prognostic factors.
Results: Nonagenarians had a substantially higher burden of comorbidities and worse pre-stroke functional status than younger patients. Successful reperfusion rates were similar between groups (92% vs. 90%). Functional independence at 90 days was achieved in 18% of nonagenarians and 50% of younger patients, while 90-day mortality was 52% and 20%, respectively. In unadjusted analyses, nonagenarians had lower odds of functional independence and higher odds of mortality. After adjustment for baseline clinical and prognostic factors, the estimated associations were attenuated, although confidence intervals remained wide and the study could not exclude a clinically relevant age-associated effect. Parenchymal hematoma occurred more frequently among nonagenarians, whereas rates of symptomatic intracerebral hemorrhage were comparable between groups.
Conclusions: In this highly selected real-world cohort, MT achieved high rates of successful reperfusion in nonagenarians, but functional outcomes and mortality were substantially less favorable than in younger patients. Adjustment for baseline clinical and prognostic factors attenuated the estimated associations, although clinically relevant age-associated differences could not be excluded. These findings support cautious, individualized treatment decisions incorporating chronological age, pre-stroke function, comorbidity burden, imaging findings, and the overall clinical profile.
Related
- Thrombophilic Variants and Clinical Outcomes in Young Ischaemic Stroke Patients Undergoing Mechanical Thrombectomy: A Retrospective Cohort Study
- Associations between inflammatory-lipid indices and clinical outcomes in ischemic stroke patients treated with mechanical thrombectomy
- Early antithrombotic therapy improves 90-day functional outcomes in patients with postinterventional cerebral hyperdensity after mechanical thrombectomy: a retrospective cohort study
- Dynamic perioperative thrombo-inflammatory biomarkers correlate with early functional outcomes after mechanical thrombectomy for acute ischemic stroke
- Outcomes of Nonagenarians Commencing Dialysis by Era in the USA
BibTeX
@article{jablonski2026mechanical,
title = {{Mechanical thrombectomy in nonagenarians: real-world outcomes from a highly selected cohort treated at a comprehensive stroke center}},
author = {Bartosz Jabłoński and Adam Wyszomirski and Aleksandra Pracoń and Marcin Stańczak and Anna Gwiazda and Łukasz Maciołek and Barbara Kołodziej-Czubacka and Edyta Szurowska and Dariusz Gąsecki and Bartosz Karaszewski},
journal = {BMC Neurology},
year = {2026},
month = aug,
doi = {10.1186/s12883-026-05253-1},
url = {https://doi.org/10.1186/s12883-026-05253-1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Mechanical thrombectomy in nonagenarians: real-world outcomes from a highly selected cohort treated at a comprehensive stroke center
AU - Bartosz Jabłoński
AU - Adam Wyszomirski
AU - Aleksandra Pracoń
AU - Marcin Stańczak
AU - Anna Gwiazda
AU - Łukasz Maciołek
AU - Barbara Kołodziej-Czubacka
AU - Edyta Szurowska
AU - Dariusz Gąsecki
AU - Bartosz Karaszewski
PY - 2026
DA - 2026/08/07
JO - BMC Neurology
DO - 10.1186/s12883-026-05253-1
UR - https://doi.org/10.1186/s12883-026-05253-1
AB - Background: Evidence supporting mechanical thrombectomy (MT) in very elderly patients remains limited, as nonagenarians are underrepresented in randomized trials and frequently excluded from MT in routine practice. We evaluated the effectiveness and safety of MT in carefully selected patients aged ≥ 90 years treated at a comprehensive stroke center. Methods: We conducted a retrospective single-center cohort study including consecutive patients with anterior circulation large vessel occlusion treated with MT. Fifty nonagenarians treated between 2017 and 2025 were compared with 100 younger patients treated in 2023. In both groups, only patients with preserved pre-stroke functional independence (modified Rankin Scale [mRS] 0–2) were included. Nonagenarians underwent detailed pre-treatment clinical assessment prior to treatment. Primary outcomes were functional independence (mRS 0–2) and all-cause mortality at 90 days. Secondary outcomes included successful reperfusion (mTICI 2b–3), neurological status at discharge, and hemorrhagic complications. Multivariable regression models were used to adjust for baseline imbalances and clinically relevant prognostic factors. Results: Nonagenarians had a substantially higher burden of comorbidities and worse pre-stroke functional status than younger patients. Successful reperfusion rates were similar between groups (92% vs. 90%). Functional independence at 90 days was achieved in 18% of nonagenarians and 50% of younger patients, while 90-day mortality was 52% and 20%, respectively. In unadjusted analyses, nonagenarians had lower odds of functional independence and higher odds of mortality. After adjustment for baseline clinical and prognostic factors, the estimated associations were attenuated, although confidence intervals remained wide and the study could not exclude a clinically relevant age-associated effect. Parenchymal hematoma occurred more frequently among nonagenarians, whereas rates of symptomatic intracerebral hemorrhage were comparable between groups. Conclusions: In this highly selected real-world cohort, MT achieved high rates of successful reperfusion in nonagenarians, but functional outcomes and mortality were substantially less favorable than in younger patients. Adjustment for baseline clinical and prognostic factors attenuated the estimated associations, although clinically relevant age-associated differences could not be excluded. These findings support cautious, individualized treatment decisions incorporating chronological age, pre-stroke function, comorbidity burden, imaging findings, and the overall clinical profile.
SN - 1471-2377
ER -